Isomer abundance of bis(β-diketonato) complexes of titanium(IV). Crystal structures of the antitumor compound budotitane [TiIV(bzac)2(OEt)2] and of its dichloro-derivative [TiIV(bzac)2Cl2] (bzac=1-phenylbutane-1,3-dionate)

Journal of Inorganic Biochemistry

Volumn 95, Issue 2-3, 2003, Pages 97-104

  Dubler, Erich ^a   Buschmann, Ralph ^a   Schmalle, Helmut W ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Budotitane; Cancer chemotherapy; Isomer distribution

Indexed keywords

1 PHENYLBUTANE 1,3 DIONATE; ACETIC ACID DERIVATIVE; ACETONE; ANTINEOPLASTIC AGENT; BENZENE DERIVATIVE; BUDOTITANE; KETONE DERIVATIVE; LIGAND; TITANIUM; UNCLASSIFIED DRUG;

ARTICLE; CENTROMERE; CONJUGATION; CRYSTAL; CRYSTAL STRUCTURE; CRYSTALLIZATION; ENANTIOMER; MOLECULE; ROOM TEMPERATURE; X RAY CRYSTALLOGRAPHY;

EID: 0037900869     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-0134(03)00091-6     Document Type: Article

References (28)

1. Rosenberg B., VanCamp L., Trosko J.E., Mansour V.H. Nature. 222:1969;385-386.
2. Lippert B. Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug. 1999;Wiley-VCH, Weinheim.
3. Sherman S.E., Lippard S.J. Chem. Rev. 87:1987;1153-1181.
4. J. Reedijk, Chem. Commun. (1996) 801-806.
5. Keppler B.K., Vogel E.A. Pinedo H.M., Schornagel J.H. Platinum and Other Coordination Compounds in Cancer Chemotherapy 2. 1996;253-268 Plenum Press, New York.
6. Keppler B.K. Metal Complexes in Cancer Therapy. 1993;297-323 VCH, Weinheim.
7. Keppler B.K., Friesen C., Moritz H.G., Vongerichten H., Vogel E. Struct. Bonding. 78:1991;97-127. and references cited therein.
8. Köpf-Maier P. Eur. J. Clin. Pharmacol. 47:1994;1-16.
9. Hartmann M., Keppler B.K. Comments Inorg. Chem. 16:1995;339-372.
10. Schilling T., Keppler B.K., Heim M.E., Niebch G., Dietzfelbinger H., Rastetter J., Hanauske A.R. Invest. New Drugs. 13:1996;327-332.
11. Clarke M.J., Zhu F., Frasca D.R. Chem. Rev. 99:1999;2511-2533.
12. Clarke M.J., Stubbs M. Sigel A., Sigel H. Metal Ions in Biological Systems. Vol. 32:1996;727-780 Marcel Dekker, New York.
13. Frühauf S., Zeller W.J. J. Cancer Res. 51:1991;2943-2948.
14. Keppler B.K., Hartmann M. Metal Based Drugs. 1:1994;145-149.
15. Sun H., Li H., Weir R.A., Sadler P.J. Angew. Chem. Int. Ed. 37:1998;1577-1579.
16. Comba P., Jakob H., Nuber B., Keppler B.K. Inorg. Chem. 33:1994;3396-3400.
17. Powder Diffraction File. 1995;JCPDS, Swarthmore, PA.
18. Stoe IPDS Software for data collection, cell refinement and data reduction, Version 2.92, Stoe and Cie, Darmstadt, 1999.
19. Coppens P., Leiserowitz L., Rabinovich D. Acta Crystallogr. 18:1965;1035-1038.
20. Sheldrick G.M. Acta Crystallogr. A. 46:1990;467-473.
21. G.M. Sheldrick, SHELXL97, University of Göttingen, Göttingen, 1997.
22. Flack H.D. Acta Crystallogr. A. 39:1983;876-881.
23. Spek A.L. Acta Crystallogr. A. 46:1990;C34.
24. A.J. Spek, PLUTON97, University of Utrecht, Utrecht, 1997.
25. Serpone N., Fay R.C. Inorg. Chem. 6:1967;1835-1843.
26. W. Oehlschläger, Ph.D. Thesis, University of Vienna, Vienna, 1996.
27. Schubert U., Buhler H., Hirle B. Chem. Ber. 125:1992;999-1003.
28. Wang J.L., Miao F.M., Fan X.J., Feng X., Wang J.T. Acta Crystallogr. C. 46:1990;1633-1635.